Urs Schanz
Has participated in:
-
Busulfan-cyclophosphamide versus cyclophosphamide-busulfan as conditioning regimen before allogeneic hematopoietic cell transplantation: a prospective randomized trial
-
Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan
-
Correction: Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with Busulfan
-
Everolimus zur Therapie der fortgeschrittenen steroidresistenten chronischen Graft-versus-Host Erkrankung nach allogener hämatopoetischer Stammzelltransplantation